{"id":245953,"date":"2025-09-22T09:00:10","date_gmt":"2025-09-22T09:00:10","guid":{"rendered":"https:\/\/www.europesays.com\/us\/245953\/"},"modified":"2025-09-22T09:00:10","modified_gmt":"2025-09-22T09:00:10","slug":"white-house-weighs-trumprx-discount-drug-website","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/245953\/","title":{"rendered":"White House Weighs ‘TrumpRx’ Discount Drug Website"},"content":{"rendered":"

The White House<\/a> is reportedly discussing a website where patients could purchase discounted prescription drugs.<\/p>\n

This site \u2014 which would potentially carry President Donald Trump\u2019s brand \u2014 would allow consumers to buy their medications straight from pharmaceutical companies, Bloomberg News reported<\/a> Friday (Sept. 19), citing sources familiar with the talks.<\/p>\n

The effort follows the administration\u2019s demands that drug companies cut prices to put them in keeping with those of other developed countries, the sources said.\u00a0<\/p>\n

The proposed website would let patients search for specific medicines and connect with platforms that sell them, the sources added. They said that officials have discussed creating a Trump brand for the website, with \u201cTrumpRx\u201d among the names being considered.<\/p>\n

According to the report, the discussions are happening ahead of a Sept. 29 deadline for drugmakers to meet Trump\u2019s demand to reduce prices<\/a> on some widely used medicines.<\/p>\n

\u201cAny reporting on internal deliberations is pure speculation until an official announcement is made by us,\u201d Department of Health and Human Services spokesperson Andrew Nixon said in a statement, adding that the administration was \u201cfully dedicated to delivering most-favored-nation pricing and lowering drug costs for the American people.\u201d<\/p>\n

Advertisement: Scroll to Continue<\/p>\n

A spokesperson for the Centers for Medicare and Medicaid Services (CMS) told Bloomberg the agency does not comment on internal deliberations.<\/p>\n

\u201cCMS is committed to carrying out President Trump\u2019s directive to lower prescription drug prices by ensuring Americans can access medications at fairer, more transparent prices and holding the pharmaceutical industry accountable,\u201d the spokesperson said.<\/p>\n

This is happening at a time when consumers across age groups are increasingly turning to digital resources for their healthcare needs.<\/p>\n

For example, the PYMNTS Intelligence\/Lynx report, \u201cThe Digital Platform Promise: What Baby Boomers and Seniors Want From Digital Healthcare Platforms\u201d<\/a> found that more than 80% of consumers want to use digital platforms to access pharmacy benefits like discount cards, and to compare information about health insurance plans and benefits.<\/p>\n

Meanwhile, PYMNTS \u201cHow the World Does Digital\u201d<\/a>\u00a0study found that younger consumers are leading the pack when it comes to digital healthcare.<\/p>\n

\u201cOn average, Gen Z logged 63 digital healthcare-related activity days a month \u2014 20 days more than the average consumer \u2014 underscoring how digital has become an integral part<\/a> of their approach to health and wellness,\u201d PYMNTS wrote earlier this year.<\/p>\n","protected":false},"excerpt":{"rendered":"The White House is reportedly discussing a website where patients could purchase discounted prescription drugs. This site \u2014…\n","protected":false},"author":3,"featured_media":245954,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[69,130759,210,1060,50,26839,11825,26198,67,132,68,756],"class_list":{"0":"post-245953","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-donald-trump","9":"tag-drug-discounts","10":"tag-health","11":"tag-medication","12":"tag-news","13":"tag-pharmaceutical-companies","14":"tag-prescription-drugs","15":"tag-prescriptions","16":"tag-united-states","17":"tag-unitedstates","18":"tag-us","19":"tag-whats-hot"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115247135498197128","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/245953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=245953"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/245953\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/245954"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=245953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=245953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=245953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}